Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2007 Apr 16;51(7):2656–2657. doi: 10.1128/AAC.01583-06

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

PMC Copyright notice

FIG. 1. — Comparison of antifungal susceptibilities of primary and relapse isolates of H. capsulatum to voriconazole and random voriconazole blood levels in patients receiving voriconazole for the treatment of histoplasmosis. The left-hand axis depicts the MIC scale for the primary and relapse isolates, included in the left-hand section of the figure. The median MIC was 0.015 μg/ml for the primary and 0.030 μg/ml for the relapse isolates. The right-hand axis depicts voriconazole blood levels for the histoplasmosis cases, included in the right-hand section of the figure. The three specimens with blood levels shown below the 0.125-μg/ml voriconazole blood level designation demonstrated a zone of inhibition in the bioassay, which was below the lowest standard. None Detected, no inhibition was observed for the specimen.